diagnosis

2025 ASH Updates: Lower Risk MDS

Thumbnail for video Register Now

Topic(s)
Myelodysplastic Syndromes (MDS)
Presenter(s)
Akriti Jain, MD
In this webinar, Dr. Akriti Jain discusses research most relevant to patients reported over the past year on the biology and treatment on Lower Risk MDS. These studies were presented at the American Society of Hematology (ASH) 2025 meeting and their findings will be explained…

2025 ASH Updates: Higher Risk MDS

Thumbnail for video Register Now

Topic(s)
Myelodysplastic Syndromes (MDS)
Presenter(s)
Rory Shallis, M.D
In this webinar, Dr. Rory Shallis discusses research most relevant to patients reported over the past year on the biology and treatment on Higher Risk MDS These studies were presented at the American Society of Hematology (ASH) 2025 meeting and their findings will be explained…

Secondary AML

Thumbnail for video Register Now

Topic(s)
Acute Myeloid Leukemia (AML)
Myelodysplastic Syndromes (MDS)
Presenter(s)
Jayastu Senapati, MBBS, MD, DM
In this webinar, Dr. Jayastu Senapati will discuss the diagnosis of secondary AML from MDS, treatment options available to patients and symptom management. Questions can be submitted in advance to help@aamds.org.

Isolated KRAS and NRAS mutations in adults with monocytosis and/or cytopenia(s)

Original Publication Date
Article Source
External Web Content

Abstract NRAS and KRAS mutations, commonly identified alongside ancestral co-mutations, are generally regarded as pathogenic in adults presenting with monocytosis and/or cytopenia(s). However, their significance in isolation is not well defined. We studied a multi-institutional…

“My labs didn’t tell the whole story” Jen’s Aplastic Anemia Journey

Jen had a great life. She was married with two children, and she’s just transitioned from teaching to school counseling. At 41, life was busy yet wonderful.

Her symptoms were unusual, but not alarming. The leg pain was new, as was the bruising. Then fatigue set in, far beyond usual tiredness from her schedule. A visit to the doctor did not offer a definitive diagnosis.  They suggested it was her condition with Hashimoto's thyroiditis, but with the new bruising, they ordered labs. It was February 2022.

ASH 2024 Research Summaries (MDS and AML)

This publication offers summaries of selected abstracts presented at the Annual Meeting of the American Hematology Society held in December 2024. It provides new and updated information about research into the diagnosis…

ASH 2025 Updates: Aplastic Anemia and PNH Webinar

Thumbnail for video Watch Now

Topic(s)
Aplastic Anemia
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Presenter(s)
Taha Bat, MD
In this webinar, Dr. Taha Bat discusses research most relevant to patients reported over the past year on the biology and treatment for Aplastic Anemia and PNH. The studies were presented at the American Society of Hematology (ASH) 2025 meeting. These findings will be explained…

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.